1. Home
  2. COSM vs TSBX Comparison

COSM vs TSBX Comparison

Compare COSM & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COSM
  • TSBX
  • Stock Information
  • Founded
  • COSM 2009
  • TSBX 2015
  • Country
  • COSM United States
  • TSBX United States
  • Employees
  • COSM N/A
  • TSBX N/A
  • Industry
  • COSM Other Pharmaceuticals
  • TSBX
  • Sector
  • COSM Health Care
  • TSBX
  • Exchange
  • COSM Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • COSM 8.2M
  • TSBX 7.7M
  • IPO Year
  • COSM 2013
  • TSBX 2023
  • Fundamental
  • Price
  • COSM $0.48
  • TSBX $0.36
  • Analyst Decision
  • COSM
  • TSBX Buy
  • Analyst Count
  • COSM 0
  • TSBX 3
  • Target Price
  • COSM N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • COSM 356.0K
  • TSBX 625.8K
  • Earning Date
  • COSM 05-15-2025
  • TSBX 05-08-2025
  • Dividend Yield
  • COSM N/A
  • TSBX N/A
  • EPS Growth
  • COSM N/A
  • TSBX N/A
  • EPS
  • COSM N/A
  • TSBX N/A
  • Revenue
  • COSM $53,554,457.00
  • TSBX N/A
  • Revenue This Year
  • COSM $28.14
  • TSBX N/A
  • Revenue Next Year
  • COSM N/A
  • TSBX N/A
  • P/E Ratio
  • COSM N/A
  • TSBX N/A
  • Revenue Growth
  • COSM N/A
  • TSBX N/A
  • 52 Week Low
  • COSM $0.28
  • TSBX $0.29
  • 52 Week High
  • COSM $1.58
  • TSBX $3.05
  • Technical
  • Relative Strength Index (RSI)
  • COSM 57.76
  • TSBX 56.52
  • Support Level
  • COSM $0.44
  • TSBX $0.32
  • Resistance Level
  • COSM $0.50
  • TSBX $0.38
  • Average True Range (ATR)
  • COSM 0.04
  • TSBX 0.03
  • MACD
  • COSM 0.00
  • TSBX 0.00
  • Stochastic Oscillator
  • COSM 75.00
  • TSBX 78.89

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: